Viral Conjunctivitis
9
0
0
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
11.1%
1 terminated out of 9 trials
88.9%
+2.4% vs benchmark
22%
2 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (9)
Viral Conjunctivitis Treatment Study
ADenoVirus Initiative Study in Epidemiology in Italy
ADenoVirus Initiative Study in Epidemiology in Germany
ADenoVirus Initiative Study in Epidemiology in Spain
Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)
ADenoVirus Initiative Study in Epidemiology in UK
ADenoVirus Initiative Study in Epidemiology in France
A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis
Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine